Non-coding Class Switch Recombination-Related Transcription in Human Normal and Pathological Immune Responses

Abstract

Antibody class switch recombination (CSR) to IgG, IgA, or IgE is a hallmark of adaptive immunity, allowing antibody function diversification beyond IgM. CSR involves a deletion of the IgM/IgD constant region genes placing a new acceptor Constant gene, downstream of the VDJH exon. CSR depends on non-coding (CSRnc) transcription of donor Iμ and acceptor IH exons, located 5′ upstream of each CH coding gene. Although, our knowledge of the role of CSRnc transcription has advanced greatly, its extension and importance in healthy and diseased humans is scarce. We analyzed CSRnc transcription in 70,603 publicly available RNA-seq samples, including GTEx, TCGA, and the Sequence Read Archive using recount2, an online resource consisting of normalized RNA-seq gene and exon counts, as well as, coverage BigWig files that can be programmatically accessed through R. CSRnc transcription was validated with a qRT-PCR assay for Iμ, Iγ3, and Iγ1 in humans in response to vaccination. We mapped IH transcription for the human IGH locus, including the less understood IGHD gene. CSRnc transcription was restricted to B cells and is widely distributed in normal adult tissues, but predominant in blood, spleen, MALT-containing tissues, visceral adipose tissue and some so-called “immune privileged” tissues. However, significant Iγ4 expression was found even in non-lymphoid fetal tissues. CSRnc expression in cancer tissues mimicked the expression of their normal counterparts, with notable pattern changes in some common cancer subsets. CSRnc transcription in tumors appears to result from tumor infiltration by B cells, since CSRnc transcription was not detected in corresponding tumor-derived immortal cell lines. Additionally, significantly increased Iδ transcription in ileal mucosa in Crohn's disease with ulceration was found. In conclusion, CSRnc transcription occurs in multiple anatomical locations beyond classical secondary lymphoid organs, representing a potentially useful marker of effector B cell responses in normal and pathological immune responses. The pattern of IH exon expression may reveal clues of the local immune response (i.e., cytokine milieu) in health and disease. This is a great example of how the public recount2 data can be used to further our understanding of transcription, including regions outside the known transcriptome.

Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature

“…The interchromosomal translocation analysis with our original CTX-explorer software (see Material and methods for details), followed by PCR and Sanger sequencing, showed that the breakpoint on chromosome 8 was located 158 kb downstream of 3′ MYC , in the PVT1 region (chr8:127,901,209) (Figs 4 and 5 ). Regarding the breakpoint on chromosome 14, it was between joining and constant IGH regions, 1.6 kb upstream of the Sμ switch region (ch14:105,862,125), according to the recently mapped IGH switch regions (Sμ: 105,856,501–105,860,500) ( S1A Fig ) [ 28 ].…”

A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients

“…The TME risk prognostic model also included immune-related genes (KLRB1 and IGHD). Proteins coded by these genes were associated with the immune microenvironment ( 52 ) and immune cell infiltration ( 53 ) (such as natural killer cells and T cells). In our study, the low-TME-risk group upregulated in many immune checkpoints and increased in most of the immune and stromal cells, including B cells, T cells CD4+, T cells CD8+, and myeloid dendritic cells.…”